Apyx Medical Corp (APYX) stock
APYXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/3035% above fair value
$3.00+0.07 (+2.39%)
Close on Nov 11, 2026Market cap $126.37MP/E –Yield –
Apyx Medical ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Apyx Medical's ebitda for the twelve months ending Sep 30, 2026 was -$2.47M. For fiscal 2025 it was -$5.79M. The highest annual figure on record is $1.79M in fiscal 2012.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$5.79M | – |
| FY2024 | Dec 31, 2024 | -$18.25M | – |
| FY2023 | Dec 31, 2023 | -$16.57M | – |
| FY2022 | Dec 31, 2022 | -$22.67M | – |
| FY2021 | Dec 31, 2021 | -$13.55M | – |
| FY2020 | Dec 31, 2020 | -$19.20M | – |
| FY2019 | Dec 31, 2019 | -$20.12M | – |
| FY2018 | Dec 31, 2018 | -$13.61M | – |
| FY2017 | Dec 31, 2017 | -$13.19M | – |
| FY2016 | Dec 31, 2016 | -$10.66M | – |
| FY2015 | Dec 31, 2015 | -$6.17M | – |
| FY2014 | Dec 31, 2014 | -$4.97M | – |
| FY2013 | Dec 31, 2013 | -$2.84M | -258.8% |
| FY2012 | Dec 31, 2012 | $1.79M | +143.3% |
| FY2011 | Dec 31, 2011 | $735.00K | – |
| FY2010 | Dec 31, 2010 | -$2.02M | -235.3% |
| FY2009 | Dec 31, 2009 | $1.49M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$384.00K | – |
| Q2 FY2026 | Jun 30, 2026 | -$1.61M | – |
| Q1 FY2026 | Mar 31, 2026 | -$709.00K | – |
| Q4 FY2025 | Dec 31, 2025 | $232.00K | – |
| Q3 FY2025 | Sep 30, 2025 | -$668.00K | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.44M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.91M | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.91M | – |
| Q3 FY2024 | Sep 30, 2024 | -$3.49M | – |
| Q2 FY2024 | Jun 30, 2024 | -$5.39M | – |
| Q1 FY2024 | Mar 31, 2024 | -$6.46M | – |
| Q4 FY2023 | Dec 31, 2023 | -$5.62M | – |
| Q3 FY2023 | Sep 30, 2023 | -$4.45M | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.08M | – |
| Q1 FY2023 | Mar 31, 2023 | -$5.41M | – |
| Q4 FY2022 | Dec 31, 2022 | -$5.73M | – |
| Q3 FY2022 | Sep 30, 2022 | -$5.57M | – |
| Q2 FY2022 | Jun 30, 2022 | -$5.73M | – |
| Q1 FY2022 | Mar 31, 2022 | -$5.65M | – |
| Q4 FY2021 | Dec 31, 2021 | -$1.46M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.73M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.83M | – |
| Q1 FY2021 | Mar 31, 2021 | -$4.52M | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.83M | – |
| Q3 FY2020 | Sep 30, 2020 | -$4.15M | – |
| Q2 FY2020 | Jun 30, 2020 | -$5.94M | – |
| Q1 FY2020 | Mar 31, 2020 | -$7.28M | – |
| Q4 FY2019 | Dec 31, 2019 | -$5.72M | – |
| Q3 FY2019 | Sep 30, 2019 | -$4.56M | – |
| Q2 FY2019 | Jun 30, 2019 | -$4.30M | – |
| Q1 FY2019 | Mar 31, 2019 | -$5.54M | – |
| Q4 FY2018 | Dec 31, 2018 | -$5.60M | – |
| Q3 FY2018 | Sep 30, 2018 | -$2.73M | – |
| Q2 FY2018 | Jun 30, 2018 | -$2.76M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.52M | – |
| Q4 FY2017 | Dec 31, 2017 | -$3.07M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.66M | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.13M | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.56M | – |
| Q4 FY2016 | Dec 31, 2016 | -$8.47M | – |
See a number that looks wrong?